Yield10 Bioscience, Inc. YTEN
0.34 0.00 (+0.00%)
Dec 20, 2024, 3:00 PM EST
0.33505 Day range 0.6949
52-week range unavailable
- Market cap
- 957.39K
- Revenue (ttm)
- 300.00K
- Shares out
- 642.55K
- Forward P/E
- -0.13
- Volume
- 11.43K
- Open
- 0.6949
- Previous close
- 0.33505
- Day's range
- 0.33505 – 0.6949
- Beta
- 1.48
- Analysts
- Hold
- Price target
- 2.50 (+646.2%)
- Earnings date
- Dec 10, 2024
2Y -67.1990 (-100.00%)
Key statistics
- Enterprise value
- 2.39M
- PEG ratio
- 0.00
- Price / sales
- 3.19
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 400.00%
- Free cash flow
- -3.33M
- Total cash
- 1.60M
- Total debt
- 3.02M
- Return on equity
- 0.00%
- Short % of float
- 0.41%
- 50-day average
- 4.56
- 200-day average
- 6.23
Analyst view
Consensus: hold
Hold
Price target (mean) 2.50
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Dec 10, 2024
Expected Dec 10, 2024. Consensus EPS estimate -4.89.
Financials — quick view
YTEN Revenue — quarterly 300.00K
YTEN Net income — quarterly -2.47M
YTEN EPS — quarterly -4.77
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 10, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Apr 1, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
| Nov 14, 2023 | Sep 1, 2023 | -7.43 | — | — | — |
| Aug 14, 2023 | Jun 1, 2023 | -11.51 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 16, 2023 | HC Wainwright & Co. | main | Buy | Buy |
| Aug 15, 2023 | Lake Street | main | Buy | Buy |
| May 10, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
| May 2, 2022 | Univest Securities | init | — | Buy |
| Apr 20, 2022 | Lake Street | init | — | Buy |
| Mar 9, 2022 | Maxim Group | main | — | Buy |
About Yield10 Bioscience, Inc.
Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- Country
- United States
- Website
- yield10bio.com
News
Yield10 Bioscience (NASDAQ:YTEN) Share Price Passes Above 200-Day Moving Average – What’s Next? 
Yield10 Bioscience (NASDAQ:YTEN) Shares Pass Above 200 Day Moving Average – Here’s What Happened 
Yield10 Bioscience Announces Adjournment of Special Meeting of Stockholders to Solicit Sufficient Votes in Favor of the Key Proposals 
Yield10 Bioscience Announces Second Quarter 2024 Financial Results 
Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets 
Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets 
Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina 
Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label 
Yield10 Bioscience Announces First Quarter 2024 Financial Results 
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Your note
Sign in to keep a note on YTEN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BRUM LYNNE H | Officer | Stock Award(Grant) | Feb 14, 2024 | 139,998 |
| HAASER CHARLES B | Officer | Stock Award(Grant) | Feb 14, 2024 | 140,861 |
| HAMILTON RICHARD WILLIAM | Director | Stock Award(Grant) | Mar 27, 2024 | 72,598 |
| PEOPLES OLIVER P | Chief Executive Officer | Stock Award(Grant) | Feb 14, 2024 | 274,181 |
| SCHULER JACK W | Beneficial Owner of more than 10% of a Class of Security | Sale | Dec 19, 2023 | 0 |
| SHAULSON JOSEPH H | Director | Stock Award(Grant) | Jun 29, 2017 | 35,295 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Cannell (Peter B.) & Company Inc | 4.23% | 258,838 | 574.62K | Jun 29, 2023 |
| Armistice Capital, LLC | 3.53% | 216,000 | 479.52K | Jun 29, 2023 |
| Vanguard Group Inc | 1.75% | 106,878 | 237.27K | Jun 29, 2023 |
| Geode Capital Management, LLC | 0.57% | 34,857 | 77.38K | Jun 29, 2023 |
| Blackrock Inc. | 0.51% | 31,380 | 69.66K | Jun 29, 2023 |
| Birchview Capital, LP | 0.31% | 18,750 | 41.63K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.08% | 65,737 | 145.94K | Jun 29, 2023 |
| Vanguard Extended Market Index Fund | 0.66% | 40,451 | 89.80K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.36% | 21,807 | 61.06K | May 30, 2023 |
| Fidelity NASDAQ Composite Index Fund | 0.12% | 7,586 | 21.24K | May 30, 2023 |
| Fidelity Series Total Market Index Fund | 0.08% | 5,106 | 14.30K | May 30, 2023 |